The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index; 15 of the 21 sources its claims cite were checked for support.
Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon
Open accessPublished version of a preprint
Abstract
The design of cereblon-binding molecular glues (MGs) that selectively recruit a desired protein while excluding teratogenic SALL4 is an area of significant interest when designing therapeutic agents. Previous studies show that SALL4 is degraded in the presence of IKZF1 degraders pomalidomide, and to a lesser extent by CC-220. To expand our understanding of the molecular basis for the interaction of SALL4 with cereblon, we performed biophysical and structural studies demonstrating that SALL4 zinc finger domains one and two (ZF1-2) interact with cereblon (CRBN) in a unique manner. ZF1 interacts with the N-terminal domain of cereblon and ZF2 binds as expected in the C-terminal IMiD-binding domain. Both ZF1 and ZF2 contribute to the potency of the interaction of ZF1-2 with CRBN:MG complexes and the affinities of SALL4 ZF1-2 for the cereblon:CC-220 complex are less potent than for the corresponding pomalidomide complex. Structural analysis provides a rationale for understanding the reduced affinity of SALL4 for cereblon in the presence of CC-220, which engages both ZF1 and ZF2. These studies further our understanding of the molecular glue-mediated interactions of zinc finger-based proteins with cereblon and may provide structural tools for the prospective design of compounds with reduced binding and degradation of SALL4.
Overview
CoChat Summary
TL;DR
This study used SPR and X-ray crystallography to compare how SALL4 zinc fingers bind cereblon in the presence of pomalidomide versus CC-220. It found that SALL4 ZF2 is the main affinity driver, ZF1 adds binding through the CRBN N-terminal domain, and CC-220 produces weaker SALL4 binding than pomalidomide.
Key findings
- By SPR, SALL4 ZF2(405–432) bound weakly to CRBN:pomalidomide with a KD of 67 μM, but extending ZF2 to include PQVKA improved affinity to 0.98 μM; adding ZF1 further improved affinity 21-fold for ZF2(405–432) and 11-fold for ZF2(405–454).
- The full ZF1-2 construct was 52-fold more potent than ZF1-2(379–432), which the authors attribute to the C-terminal PQVKA residues; ZF2 was described as the primary determinant of binding affinity.
- X-ray structures of SALL4 ZF1-2 with DDB1:CRBN:MG complexes were solved at 2.9 Å (CC-220), 3.0 Å (pomalidomide), and 3.1 Å for the longer ZF1-2(370–454) with pomalidomide.
- For ZF1-2(379–432) K389A, affinity for CRBN:pomalidomide was similar to native (4.4 ± 0.3 μM vs 2.9 ± 0.4 μM), but for CRBN:CC-220 the mutant bound better (64 ± 3.7 μM vs 166 ± 27 μM), supporting a CC-220-specific interaction with K389.
Methods
- The authors performed surface plasmon resonance (SPR) binding assays using immobilized DDB1:CRBN and a fixed 5 μM concentration of pomalidomide or CC-220 to measure SALL4 zinc-finger interactions.
- They determined X-ray crystal structures of DDB1:CRBN complexes with SALL4 ZF1-2 and either pomalidomide or CC-220, plus a longer SALL4 construct with pomalidomide.
- Protein constructs were expressed in E. coli or Sf21 cells and purified by affinity chromatography and size exclusion chromatography; structural comparison and contact analysis were done with MOE.
Limitations
- The paper does not report a cellular or in vivo test of whether the structural differences translate into differences in SALL4 degradation; this is evident from the text.
- The structural conclusions are based on truncated SALL4 constructs rather than full-length SALL4; this is evident from the text.
- The paper does not state all complete SPR datasets in the excerpted text, and some details are deferred to Supplementary Data Table 1; this is stated in the paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
9 Valid · 0 Not valid · 4 Not checked · 68 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“MGs can recruit or degrade more than one target; for example, pomalidomide (POM) and CC-220 recruit and degrade transcription factor IKZF1 along with SALL4 and several other targets3,5,6.”
§ Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon > Introduction
What the sources say
- Partly supportedcites [3] Sievers, Q. L. et al. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science 362, 6414. https://doi.org/10.1126/science.aat0572 (2018). sourceExperimental — accuracy not yet measured
The C2H2 ZF library screen reports pomalidomide-induced degradation of IKZF1 and several other full-length proteins. The in silico identification section reports that SALL4 binds pomalidomide-engaged CRBN, but says only WIZ among the 16 newly tested zinc fingers showed partial degradation; it does not establish SALL4 degradation. The section on distinct analog targets discusses CC-220 degradation of zinc fingers, but does not establish the full claimed combination of targets for CC-220. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [5] Matyskiela, M. E. et al. A cereblon modulator (CC-220) with improved degradation of Ikaros and Aiolos. J. Med. Chem. 61(2), 535–542. https://doi.org/10.1021/acs.jmedchem.6b01921 (2018). source
- Partly supportedcites [6] Donovan, K. A. et al. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane radial ray syndrome. Elife 7, e38430. https://doi.org/10.7554/eLife.38430 (2018). sourceExperimental — accuracy not yet measured
The Results report that pomalidomide degrades SALL4 and several additional targets, and the Discussion says CC-220 can induce SALL4 degradation. The Introduction identifies IKZF1 as an IMiD degradation target, but the passages do not specifically establish that both pomalidomide and CC-220 recruit and degrade IKZF1 or that CC-220 degrades several other targets. (LLM, conf=0.81)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, the addition of C-terminal residues PQVKA to SALL4 ZF2 results in increased degradation relative to ZF2 alone13.”
§ Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon > Introduction
What the sources say
- Partly supportedcites [13] Yamanaka, S. et al. An IMiD-induced SALL4 degron system for selective degradation of target proteins. Commun. Biol. 3(1), 515. https://doi.org/10.1038/s42003-020-01240-5 (2020). sourceExperimental — accuracy not yet measured
The Results section (“Construction of the IMiD-induced SALL4 degron tag”; page unavailable) compares constructs ending at residues 437 and 432: the longer construct was degraded after IMiD treatment, while the shorter one was not. Our copy does not identify the five added C-terminal residues as PQVKA, so it supports the degradation comparison but not that specific sequence. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Additionally, it is the third binding mode for ZFs to CRBN:MG complexes adding to our understanding of the binding of single zinc fingers such as IKZF13,7 and ZNF6923, and the binding of two zinc fingers including C-terminal ancillary ZF3 in the IKZF2 ZF2-3 complex9,10.”
§ Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon > Discussion
What the sources say
- Supportedcites [3] Sievers, Q. L. et al. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science 362, 6414. https://doi.org/10.1126/science.aat0572 (2018). source
In “Structures of CRBN bound to pomalidomide and two different ZF degrons” (page unavailable), the paper reports a structure of the single zinc finger ZNF692 ZF4 bound to pomalidomide-engaged CRBN. The citation follows ZNF692 in the citing sentence and supports that example; the description of a “third binding mode” is the citing authors’ framing, not a finding attributed specifically to this source. (LLM, conf=0.90)
- Partly supportedcites [7] Watson, E. R. et al. Molecular glue CELMoD compounds are regulators of cereblon conformation. Science 378(6619), 549–553. https://doi.org/10.1126/science.add7574 (2022). sourceExperimental — accuracy not yet measured
The passage on Ikaros recruitment (section labeled Abstract; page unavailable) supports binding of a single zinc-finger motif to a molecular-glue-bound CRBN complex. It does not establish a third binding mode or describe an IKZF2 ZF2–3 complex with an ancillary ZF3, so those details are not supported by this source. (LLM, conf=0.82)
- Partly supportedcites [9] Wang, E. S. et al. Acute pharmacological degradation of Helios destabilizes regulatory T cells. Nat. Chem. Biol. 17(6), 711–717. https://doi.org/10.1038/s41589-021-00802-w (2021). sourceExperimental — accuracy not yet measured
The Results section (page unavailable) describes a binding mode for a single IKZF2 zinc finger, ZnF2, in a CRBN–ALV1 complex. It does not establish that this is the third binding mode or describe binding by the two-finger IKZF2 ZF2–3 complex with an ancillary ZF3. (LLM, conf=0.86)
- Partly supportedcites [10] Bonazzi, S. et al. Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy. Cell Chem. Biol. 30(3), 235–247. https://doi.org/10.1016/j.chembiol.2023.02.005 (2023). sourceExperimental — accuracy not yet measured
In the structural characterization passages (page not provided), the paper describes an IKZF2 ZF2–ZF3 complex in which ZF3 wraps around CRBN and adds to the binding interface. That supports the two-zinc-finger mode cited in the sentence, but our copy does not identify it as the third binding mode for zinc fingers in CRBN–molecular-glue complexes. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Extension of ZF2 to include the C-terminal sequence PQVKA identified previously in cellular degradation studies13 resulted in a KD of 0.98 μM, a 68-fold improvement in affinity of ZF2(405–437) relative to ZF2(405–432).”
§ Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon > Results > Determination of the MG-mediated binding affinities of SALL4 zinc finger domains to cereblon by SPR To identify the minimal SALL4 binding domain that interacts with human cereblon complexed with IMiD molecules pomalidomide and CC-220, we examined the SPR binding affinities of SALL4 zinc finger domains 1, 2, and ZF1-2 to DDB1:CRBN:MG complexes (Table 1 and Fig. 1). In these experiments, the concentration of pomalidomide or CC-220 was fixed at 5 μM, which results in near saturation of cereblon since the KD values for the interaction of these molecules with DDB1:CRBN are 170 ± 0.30 and 9 ± 0.9 nM, respectively (Fig. S1). Measuring the interaction of a dilution series of ZF(s) with the DDB1:CRBN:MG complex results in the determination of the affinity of the ZF(s) for the DDB1:CRBN:MG complex. For the DDB1:CRBN:POM complex, ZF1(370–409) shows no detectable binding at 25 μM, and ZF2(405–432) binds weakly to the CRBN:POM complex with a KD of 67 μM. Extension of ZF2 to include the C-terminal sequence PQVKA identified previously in cellular degradation studies13 resulted in a KD of 0.98 μM, a 68-fold improvement in affinity of ZF2(405–437) relative to ZF2(405–432). Further extension of the C-terminus to ZF2(405–454) did not result in further improvements. The addition of ZF1 to ZF2(405–432) and ZF2(405–454) results in 21- and 11-fold improvements in affinity for the interaction of these ZFs with the CRBN:POM complex, respectively, suggesting that both ZF1 and ZF2 interact with cereblon. The affinity of ZF1-2(370–454) is 52-fold more potent than ZF1-2(379–432), likely due to the inclusion of the PQVKA residues that resulted in more potent affinity for ZF2(405–437). Analysis of the same ZFs with the DDB1:CRBN:CC-220 complex resulted in the same trends, but the affinities were less potent than for the interaction of ZF2 alone and ZF1-2 with the CRBN:POM complex. Overall, these findings are consistent with engagement of both SALL4 ZF1 and ZF2 with CRBN:MG complexes as well as the previously reported involvement of C-terminal ZF2 extension PQVKA. Since the affinity of ZF2 alone is more potent than ZF1, ZF2 is the primary determinant of binding affinity in the ZF1-2 complex. Furthermore, the differences in affinities of SALL4 ZF domains for the DDB1:CRBN:CC-220 complex are consistently weaker than those in the corresponding DDB1:CRBN:POM complex suggesting that the interactions of these ZF domains with the CRBN:MG complex are distinct.
What the sources say
- Supportedcites [13] Yamanaka, S. et al. An IMiD-induced SALL4 degron system for selective degradation of target proteins. Commun. Biol. 3(1), 515. https://doi.org/10.1038/s42003-020-01240-5 (2020). source
The citation is attached to the prior identification of the C-terminal extension in cellular degradation studies, not to the KD or 68-fold affinity measurement. In Results, ‘Construction of the IMiD-induced SALL4 degron tag’ (page unavailable), the paper compares constructs ending at residues 437 and 432 and reports that the longer constructs underwent IMiD-induced degradation in cells, whereas the shorter one did not. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Like ZF2-3 of IKZF1 and IKZF2, SALL4 ZF1-2 binds more tightly to CRBN:MG complexes than ZF2 alone6.”
§ Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon > Introduction
What the sources say
- Supportedcites [6] Donovan, K. A. et al. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane radial ray syndrome. Elife 7, e38430. https://doi.org/10.7554/eLife.38430 (2018). source
The Results section, “In vitro binding assays confirm IMiD-dependent binding of SALL4 to CRL4CRBN” (Figure 3D–E), reports that the SALL4 ZnF1-2 construct bound CRBN more tightly than ZnF2 alone in IMiD-dependent in vitro assays. This supports the attributed comparison for CRBN–molecular-glue complexes. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
50 more claims
Create a free account to see all 81 claims and every source verdict.
- Probably not a substantial claim. 5
- It may state two separate claims as one. 24
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Towards automated crystallographic structure refinement with phenix.refine
Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H., & Adams, P. D. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444912001308 · Cited by 5,511
A graphical user interface to the CCP 4 program suite
Potterton, E., Briggs, P., Turkenburg, M., & Dodson, E. (2003) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444903008126 · Cited by 1,212
Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
Petzold, G., Fischer, E. S., & Thomä, N. H. (2016) · Nature · doi:10.1038/nature16979 · Cited by 620
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
Sievers, Q. L., Petzold, G., Bunker, R. D., Renneville, A., Słabicki, M., Liddicoat, B. J., Abdulrahman, W., Mikkelsen, T., Ebert, B. L., & Thomä, N. H. (2018) · Science · doi:10.1126/science.aat0572 · Cited by 537
Donovan, K. A., An, J., Nowak, R. P., Yuan, J. C., Fink, E. C., Berry, B. C., Ebert, B. L., & Fischer, E. S. (2018) · eLife · doi:10.7554/elife.38430 · Cited by 509 · cited 2×
“Studies have shown that protein degradation is chemotype dependent and that single atom changes among lenalidomide and pomalidomide result in the degradation of different protein populations 3,6 , yet the origin of the observed selectivity for a given target (or targets) is unclear.”
BackgroundDevelopment of targeted protein degradation therapeutics
Chamberlain, P. P., & Hamann, L. G. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0362-y · Cited by 489
Site-Specific Biotinylation of Purified Proteins Using BirA
Fairhead, M., & Howarth, M. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2272-7_12 · Cited by 395 · cited 2×
“Avi-tagged CRBN was labeled at 100% efficiency with biotin using BirA enzyme.”
MethodSALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate
Matyskiela, M. E., Couto, S., Zheng, X., Lu, G., Hui, J., Stamp, K., Drew, C., Ren, Y., Wang, M., Carpenter, A., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0129-x · Cited by 338 · cited 1×
“To determine the minimal binding domain recruited by these molecules, we chose to focus on ZF2, which is essential for degradation, and adjacent ZF1, which was implicated in biochemical binding studies 6,8,12 .”
Background
Cited by
Design of a Cereblon construct for crystallographic and biophysical studies of protein degraders
Kroupova, A., Spiteri, V. A., Rutter, Z. J., Furihata, H., Darren, D., Ramachandran, S., Chakraborti, S., Haubrich, K., Pethe, J., Gonzales, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52871-9 · Cited by 47
“In our second approach, we used the Protein Repair One-Stop Shop (PROSS) server 47 to identify amino acid substitutions that would positively contribute to protein stability and solubility.”
MethodHigh-throughput ligand diversification to discover chemical inducers of proximity
Shaum, J. B., Ordoño, M. M. I., Steen, E. A., Wenge, D. V., Cheong, H., Janowski, J., Hunkeler, M., Bilotta, E. M., Rutter, Z. J., Barta, P. A., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02137-2 · Cited by 44
“This revealed that a peripheral loop in the N-terminal domain of CRBN (amino acids 146–153) is brought closer to the ENL YEATS domain than in any other structure (median root-mean-square deviation (r.m.s.d.) = 3.8 Å) and contributes to the high degree of shape complementarity between CRBN and ENL…”
InfluentialUnleashing the Power of Covalent Drugs for Protein Degradation
Fu, M., Jin, H., Wang, S., Shen, L., Liu, H., Liu, Y., Zheng, Y., & Dai, X. (2025) · Medicinal Research Reviews · doi:10.1002/med.22101 · Cited by 34
Nutt, M. J., & Stewart, S. G. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104010 · Cited by 24
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradation
Slabicki, M. M., Park, J., Nowak, R. P., Burman, S. S. R., Pellman, J., Zou, C., Razumkov, H., Carreiro, J., Rastogi, S., Goldstein, A., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.07.019 · Cited by 20
Metadata
- Authors
- Ma, X., Leon, B., Ornelas, E., Dovala, D., Tandeske, L., Luu, C., Pardee, G., Widger, S., Solomon, J. M., Beckwith, R. E. J., Moser, H., Clifton, M. C., & Wartchow, C. A.
- Affiliations
- Novartis (United States) (US)
- Corresponding author
- Wartchow, Charles A.
- ORCID
- Venue
- Scientific Reports
- Published
- 2023-12-12
- Volume
- 13
- Issue
- 1
- Pages
- 22088-22088
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC10716131
- OpenAlex
- W4389607241
- Semantic Scholar
- c3e8638563d4a10faf2e08d6c0074a032d2c9e82
- Cited by
- 21
- References
- 21
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 7
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Research Square (submittedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- The Novartis Repository (Novartis) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- The Novartis Repository (Novartis) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- SALL4, cereblon, pomalidomide, molecular glues, zinc finger, protein-protein interaction, protein structure, binding affinity
- MeSH terms
- Morpholines, Phthalimides, Piperidones, Teratogens, Thalidomide, Zinc Fingers, Ubiquitin-Protein Ligases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon. https://app.cochat.ai/papers/10.1038/s41598-023-48606-3
- The paper
- Ma, X., Leon, B., Ornelas, E., Dovala, D., Tandeske, L., Luu, C., Pardee, G., Widger, S., Solomon, J. M., Beckwith, R. E. J., Moser, H., Clifton, M. C., & Wartchow, C. A. (2023). Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon. Scientific Reports. https://doi.org/10.1038/s41598-023-48606-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.